Sernova (TSE:SVA) Reaches New 1-Year Low at $0.37

Sernova Corp. (TSE:SVA)’s stock price reached a new 52-week low on Monday . The stock traded as low as C$0.37 and last traded at C$0.37, with a volume of 144113 shares trading hands. The stock had previously closed at C$0.40.

Analyst Upgrades and Downgrades

Separately, Raymond James set a C$1.50 target price on shares of Sernova and gave the company a “market perform” rating in a research note on Thursday, April 4th.

Sernova Trading Down 7.5 %

The company’s fifty day simple moving average is C$0.50 and its 200-day simple moving average is C$0.62. The firm has a market capitalization of C$112.26 million, a PE ratio of -2.85 and a beta of 1.60. The company has a debt-to-equity ratio of 16.55, a current ratio of 1.20 and a quick ratio of 18.11.

Sernova (TSE:SVA) last issued its quarterly earnings results on Monday, March 18th. The company reported C($0.03) earnings per share for the quarter, meeting analysts’ consensus estimates of C($0.03). As a group, sell-side analysts expect that Sernova Corp. will post -0.08 earnings per share for the current fiscal year.

About Sernova

Sernova Corp. operates as a clinical-stage regenerative medicine therapeutics company in Canada. The company focuses on the development and commercialization of regenerative medicine therapeutics, including its proprietary Cell Pouch and associated technologies consisting of therapeutic cells and local cellular immune protection.